Total Payments
$4,136
2024 Payments
$297.14
Companies
20
Transactions
192
Medicare Patients
13,497
Medicare Billing
$713,990
Payment Breakdown by Category
Food & Beverage$3,451 (83.4%)
Travel$678.23 (16.4%)
Education$7.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,451 | 188 | 83.4% |
| Travel and Lodging | $678.23 | 3 | 16.4% |
| Education | $7.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,131 | 74 | $0 (2024) |
| Medtronic Vascular, Inc. | $887.92 | 10 | $0 (2017) |
| PFIZER INC. | $452.28 | 29 | $0 (2024) |
| Amgen Inc. | $224.10 | 13 | $0 (2024) |
| Abbott Laboratories | $186.11 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $162.83 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $159.29 | 11 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $141.35 | 4 | $0 (2019) |
| Edwards Lifesciences Corporation | $135.65 | 2 | $0 (2020) |
| HeartFlow, Inc. | $130.76 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.14 | 17 | Novartis Pharmaceuticals Corporation ($183.30) |
| 2023 | $239.24 | 14 | Novartis Pharmaceuticals Corporation ($142.08) |
| 2022 | $386.80 | 18 | Novartis Pharmaceuticals Corporation ($169.36) |
| 2021 | $199.98 | 17 | Novartis Pharmaceuticals Corporation ($186.56) |
| 2020 | $170.88 | 4 | Edwards Lifesciences Corporation ($111.89) |
| 2019 | $976.56 | 54 | Novartis Pharmaceuticals Corporation ($258.70) |
| 2018 | $802.23 | 47 | PFIZER INC. ($181.49) |
| 2017 | $1,063 | 21 | Medtronic Vascular, Inc. ($887.92) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Heart Failure | ||||||
| 12/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Heart Failure | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/03/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Not Applicable | ||||||
| 10/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Heart Failure | ||||||
| 06/28/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Heart Failure | ||||||
| 06/28/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Heart Failure | ||||||
| 04/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,618 | 4,387 | $868,384 | $185,902 |
| 2022 | 24 | 3,508 | 4,163 | $845,651 | $186,919 |
| 2021 | 25 | 3,458 | 3,916 | $868,986 | $187,496 |
| 2020 | 21 | 2,913 | 3,350 | $709,299 | $153,673 |
Total Patients
13,497
Total Services
15,816
Medicare Billing
$713,990
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 439 | 560 | $137,760 | $51,585 | 37.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 272 | 445 | $64,080 | $29,518 | 46.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 196 | 203 | $57,043 | $22,131 | 38.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 292 | 294 | $176,694 | $15,981 | 9.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 253 | 253 | $152,053 | $13,060 | 8.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 147 | $25,725 | $10,242 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $29,155 | $10,168 | 34.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 498 | 586 | $46,880 | $6,433 | 13.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 655 | 722 | $25,270 | $4,619 | 18.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 56 | 56 | $12,880 | $3,127 | 24.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 22 | 321 | $10,593 | $2,762 | 26.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 32 | 32 | $11,296 | $2,709 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,840 | $1,777 | 36.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 30 | 30 | $6,300 | $1,449 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 16 | $4,033 | $1,330 | 33.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 118 | 118 | $11,682 | $1,166 | 10.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 55 | 56 | $28,000 | $1,115 | 4.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 21 | 21 | $4,410 | $1,050 | 23.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 15 | $3,105 | $994.22 | 32.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 79 | 79 | $7,821 | $869.90 | 11.1% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 38 | 38 | $2,660 | $763.80 | 28.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $1,116 | $517.44 | 46.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 27 | 27 | $13,500 | $515.13 | 3.8% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 25 | 25 | $1,750 | $489.21 | 28.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 32 | 32 | $9,600 | $452.60 | 4.7% |
About Dr. Narayan Saha, M.D
Dr. Narayan Saha, M.D is a Cardiovascular Disease healthcare provider based in Arlington Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1396033825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Narayan Saha, M.D has received a total of $4,136 in payments from pharmaceutical and medical device companies, with $297.14 received in 2024. These payments were reported across 192 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,451).
As a Medicare-enrolled provider, Saha has provided services to 13,497 Medicare beneficiaries, totaling 15,816 services with total Medicare billing of $713,990. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Arlington Heights, IL
- Active Since 07/18/2011
- Last Updated 07/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396033825
Products in Payments
- ENTRESTO (Drug) $798.60
- LEQVIO (Drug) $331.90
- CHANTIX (Drug) $307.77
- ELIQUIS (Drug) $218.17
- Corlanor (Drug) $177.10
- CARDIOMEMS (Device) $172.03
- XARELTO (Drug) $162.83
- LifeVest (Device) $141.35
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $135.65
- FFRct (Device) $130.76
- PRALUENT (Drug) $100.51
- BRILINTA (Drug) $84.67
- VYNDAQEL (Drug) $64.63
- NORTHERA (Drug) $54.25
- PRADAXA (Drug) $51.72
- PRALUENT (Biological) $50.95
- PRALUENT ALIROCUMAB INJECTION (Biological) $48.31
- Repatha (Biological) $47.00
- BEVYXXA (Drug) $38.45
- Vascepa (Drug) $36.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Arlington Heights
Dr. Steven Lupovitch, M.d, M.D
Cardiovascular Disease — Payments: $41,286
Cardiovascular Disease $41,286
Michael Bauer, M.d, M.D
Cardiovascular Disease — Payments: $13,626
Cardiovascular Disease $13,626
Alan Spiegel, M.d, M.D
Cardiovascular Disease — Payments: $12,017
Cardiovascular Disease $12,017
Dr. Stephen Zaacks, M.d, M.D
Cardiovascular Disease — Payments: $8,795
Cardiovascular Disease $8,795
William Suhr, M.d, M.D
Cardiovascular Disease — Payments: $3,515
Cardiovascular Disease $3,515
Dr. Paul Ruzumna, M.d, M.D
Cardiovascular Disease — Payments: $2,479
Cardiovascular Disease $2,479